Dale J. Christensen
Keine laufenden Positionen mehr
Profil
Dale J.
Christensen worked as a Director, VP-Research & Business Development at Cognosci, Inc., Principal at Affinergy LLC, Vice President-Preclinical Development at Spyryx Biosciences, Inc., Principal at Karobio Usa, Principal at Aryzun Pharmaceuticals, and Head-Clinical Development at TFF Pharmaceuticals, Inc. He holds a doctorate from the University of Utah and an undergraduate degree from Utah State University.
Ehemalige bekannte Positionen von Dale J. Christensen
| Unternehmen | Position | Ende |
|---|---|---|
| TFF PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
Spyryx Biosciences, Inc.
 Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Spyryx Biosciences, Inc. develops therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and chronic obstructive pulmonary disease. The company was founded by Robert Tarran in 2013 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
| Aryzun Pharmaceuticals | Corporate Officer/Principal | - |
| Karobio Usa | Corporate Officer/Principal | - |
Affinergy LLC
 Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Ausbildung von Dale J. Christensen
| University of Utah | Doctorate Degree |
| Utah State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TFF PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Health Technology |
Spyryx Biosciences, Inc.
Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Spyryx Biosciences, Inc. develops therapeutics for obstructive lung diseases with a particular focus on Cystic Fibrosis and chronic obstructive pulmonary disease. The company was founded by Robert Tarran in 2013 and is headquartered in Durham, NC. | Health Technology |
Cognosci, Inc.
 Cognosci, Inc. Medical DistributorsDistribution Services Cognosci, Inc. develops anti-inflammatory compounds for the treatment of neuroinflammatory diseases, including multiple sclerosis, Alzheimer's disease and brain bleeding events. The company was founded by Michael P. Vitek in May 2005 and is headquartered in Durham, NC. | Distribution Services |
| Karobio Usa | |
| Aryzun Pharmaceuticals |
